PPARG and Insulin resistance: ADPQ has been found to have the ability to reduce insulin resistance (IR) through the activation of specific proteins, such as adenosine monophosphate-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma (PPAR-γ).